Industry Research Reports
Home > Reports > Service & Software > Global AI-driven Peptide Drug Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
Global AI-driven Peptide Drug Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 149 Pages
Report ld: 4858918
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
AI-driven Peptide Drug Discovery Platform Market Size(US$)
CAGR 2025-2031
9.2%
Market Size,2031
USD 1,324
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 779 million
Market Forecast in 2031(Value)
US$ 1,324 million
CAGR
9.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ 715 million in 2024 to US$ 1324 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and Schrödinger and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's "14th Five-Year Plan for Bioeconomic Development" policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI-driven Peptide Drug Discovery Platform market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Peptilogics
- Pepticom Ltd
- Menten AI
- GUBRA
- Creative Peptides
- Exscalate
- Generate Biomedicines
- Receptor.AI
- Insilico Medicine
- Schrödinger
- BenevolentAI
- Evotec
- PeptiFinder
- Xtalpi
- Sun Novo
- Zonsen Peplib Biotech
- Tide Tron Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Design and Generation Platform
- Screening and Optimization Platform
- Data-driven Platform
- Others
Segment by Application
- Scientific Research
- Pharmaceuticals
CHAPTER OUTLINE
Chapter 1: Defines the AI-driven Peptide Drug Discovery Platform study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to AI-driven Peptide Drug Discovery Platform: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Design and Generation Platform
1.2.3 Screening and Optimization Platform
1.2.4 Data-driven Platform
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Pharmaceuticals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI-driven Peptide Drug Discovery Platform Revenue Estimates and Forecasts 2020-2031
2.2 Global AI-driven Peptide Drug Discovery Platform Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI-driven Peptide Drug Discovery Platform Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI-driven Peptide Drug Discovery Platform Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Design and Generation Platform Market Size by Players
3.3.2 Screening and Optimization Platform Market Size by Players
3.3.3 Data-driven Platform Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global AI-driven Peptide Drug Discovery Platform Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI-driven Peptide Drug Discovery Platform Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)
6.4 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI-driven Peptide Drug Discovery Platform Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)
7.4 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)
8.4 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)
9.4 Central and South America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI-driven Peptide Drug Discovery Platform Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)
10.4 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Peptilogics
11.1.1 Peptilogics Corporation Information
11.1.2 Peptilogics Business Overview
11.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.1.5 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024
11.1.6 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024
11.1.7 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024
11.1.8 Peptilogics AI-driven Peptide Drug Discovery Platform SWOT Analysis
11.1.9 Peptilogics Recent Developments
11.2 Pepticom Ltd
11.2.1 Pepticom Ltd Corporation Information
11.2.2 Pepticom Ltd Business Overview
11.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.2.5 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024
11.2.6 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024
11.2.7 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024
11.2.8 Pepticom Ltd AI-driven Peptide Drug Discovery Platform SWOT Analysis
11.2.9 Pepticom Ltd Recent Developments
11.3 Menten AI
11.3.1 Menten AI Corporation Information
11.3.2 Menten AI Business Overview
11.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.3.5 Menten AI AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024
11.3.6 Menten AI AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024
11.3.7 Menten AI AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024
11.3.8 Menten AI AI-driven Peptide Drug Discovery Platform SWOT Analysis
11.3.9 Menten AI Recent Developments
11.4 GUBRA
11.4.1 GUBRA Corporation Information
11.4.2 GUBRA Business Overview
11.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.4.5 GUBRA AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024
11.4.6 GUBRA AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024
11.4.7 GUBRA AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024
11.4.8 GUBRA AI-driven Peptide Drug Discovery Platform SWOT Analysis
11.4.9 GUBRA Recent Developments
11.5 Creative Peptides
11.5.1 Creative Peptides Corporation Information
11.5.2 Creative Peptides Business Overview
11.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.5.5 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024
11.5.6 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024
11.5.7 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024
11.5.8 Creative Peptides AI-driven Peptide Drug Discovery Platform SWOT Analysis
11.5.9 Creative Peptides Recent Developments
11.6 Exscalate
11.6.1 Exscalate Corporation Information
11.6.2 Exscalate Business Overview
11.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.6.5 Exscalate Recent Developments
11.7 Generate Biomedicines
11.7.1 Generate Biomedicines Corporation Information
11.7.2 Generate Biomedicines Business Overview
11.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.7.5 Generate Biomedicines Recent Developments
11.8 Receptor.AI
11.8.1 Receptor.AI Corporation Information
11.8.2 Receptor.AI Business Overview
11.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.8.5 Receptor.AI Recent Developments
11.9 Insilico Medicine
11.9.1 Insilico Medicine Corporation Information
11.9.2 Insilico Medicine Business Overview
11.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.9.5 Insilico Medicine Recent Developments
11.10 Schrödinger
11.10.1 Schrödinger Corporation Information
11.10.2 Schrödinger Business Overview
11.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BenevolentAI
11.11.1 BenevolentAI Corporation Information
11.11.2 BenevolentAI Business Overview
11.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.11.5 BenevolentAI Recent Developments
11.12 Evotec
11.12.1 Evotec Corporation Information
11.12.2 Evotec Business Overview
11.12.3 Evotec AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.12.4 Evotec AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.12.5 Evotec Recent Developments
11.13 PeptiFinder
11.13.1 PeptiFinder Corporation Information
11.13.2 PeptiFinder Business Overview
11.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.13.5 PeptiFinder Recent Developments
11.14 Xtalpi
11.14.1 Xtalpi Corporation Information
11.14.2 Xtalpi Business Overview
11.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.14.5 Xtalpi Recent Developments
11.15 Sun Novo
11.15.1 Sun Novo Corporation Information
11.15.2 Sun Novo Business Overview
11.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.15.5 Sun Novo Recent Developments
11.16 Zonsen Peplib Biotech
11.16.1 Zonsen Peplib Biotech Corporation Information
11.16.2 Zonsen Peplib Biotech Business Overview
11.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.16.5 Zonsen Peplib Biotech Recent Developments
11.17 Tide Tron Biotech
11.17.1 Tide Tron Biotech Corporation Information
11.17.2 Tide Tron Biotech Business Overview
11.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Features and Attributes
11.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)
11.17.5 Tide Tron Biotech Recent Developments
12 AI-driven Peptide Drug Discovery PlatformIndustry Chain Analysis
12.1 AI-driven Peptide Drug Discovery Platform Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI-driven Peptide Drug Discovery Platform Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI-driven Peptide Drug Discovery Platform Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI-driven Peptide Drug Discovery Platform Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI-driven Peptide Drug Discovery Platform Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI-driven Peptide Drug Discovery Platform Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI-driven Peptide Drug Discovery Platform by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Peptide Drug Discovery Platform as of 2024)
Table 11. Global AI-driven Peptide Drug Discovery Platform Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI-driven Peptide Drug Discovery Platform Companies Headquarters
Table 13. Global AI-driven Peptide Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI-driven Peptide Drug Discovery Platform High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI-driven Peptide Drug Discovery Platform Growth Accelerators and Market Barriers
Table 25. North America AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI-driven Peptide Drug Discovery Platform Growth Accelerators and Market Barriers
Table 27. Europe AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI-driven Peptide Drug Discovery Platform Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI-driven Peptide Drug Discovery Platform Investment Opportunities and Key Challenges
Table 31. Central and South America AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI-driven Peptide Drug Discovery Platform Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Peptilogics Corporation Information
Table 35. Peptilogics Description and Major Businesses
Table 36. Peptilogics Product Features and Attributes
Table 37. Peptilogics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Peptilogics Revenue Proportion by Product in 2024
Table 39. Peptilogics Revenue Proportion by Application in 2024
Table 40. Peptilogics Revenue Proportion by Geographic Area in 2024
Table 41. Peptilogics AI-driven Peptide Drug Discovery Platform SWOT Analysis
Table 42. Peptilogics Recent Developments
Table 43. Pepticom Ltd Corporation Information
Table 44. Pepticom Ltd Description and Major Businesses
Table 45. Pepticom Ltd Product Features and Attributes
Table 46. Pepticom Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Pepticom Ltd Revenue Proportion by Product in 2024
Table 48. Pepticom Ltd Revenue Proportion by Application in 2024
Table 49. Pepticom Ltd Revenue Proportion by Geographic Area in 2024
Table 50. Pepticom Ltd AI-driven Peptide Drug Discovery Platform SWOT Analysis
Table 51. Pepticom Ltd Recent Developments
Table 52. Menten AI Corporation Information
Table 53. Menten AI Description and Major Businesses
Table 54. Menten AI Product Features and Attributes
Table 55. Menten AI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Menten AI Revenue Proportion by Product in 2024
Table 57. Menten AI Revenue Proportion by Application in 2024
Table 58. Menten AI Revenue Proportion by Geographic Area in 2024
Table 59. Menten AI AI-driven Peptide Drug Discovery Platform SWOT Analysis
Table 60. Menten AI Recent Developments
Table 61. GUBRA Corporation Information
Table 62. GUBRA Description and Major Businesses
Table 63. GUBRA Product Features and Attributes
Table 64. GUBRA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. GUBRA Revenue Proportion by Product in 2024
Table 66. GUBRA Revenue Proportion by Application in 2024
Table 67. GUBRA Revenue Proportion by Geographic Area in 2024
Table 68. GUBRA AI-driven Peptide Drug Discovery Platform SWOT Analysis
Table 69. GUBRA Recent Developments
Table 70. Creative Peptides Corporation Information
Table 71. Creative Peptides Description and Major Businesses
Table 72. Creative Peptides Product Features and Attributes
Table 73. Creative Peptides Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Creative Peptides Revenue Proportion by Product in 2024
Table 75. Creative Peptides Revenue Proportion by Application in 2024
Table 76. Creative Peptides Revenue Proportion by Geographic Area in 2024
Table 77. Creative Peptides AI-driven Peptide Drug Discovery Platform SWOT Analysis
Table 78. Creative Peptides Recent Developments
Table 79. Exscalate Corporation Information
Table 80. Exscalate Description and Major Businesses
Table 81. Exscalate Product Features and Attributes
Table 82. Exscalate Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Exscalate Recent Developments
Table 84. Generate Biomedicines Corporation Information
Table 85. Generate Biomedicines Description and Major Businesses
Table 86. Generate Biomedicines Product Features and Attributes
Table 87. Generate Biomedicines Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Generate Biomedicines Recent Developments
Table 89. Receptor.AI Corporation Information
Table 90. Receptor.AI Description and Major Businesses
Table 91. Receptor.AI Product Features and Attributes
Table 92. Receptor.AI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Receptor.AI Recent Developments
Table 94. Insilico Medicine Corporation Information
Table 95. Insilico Medicine Description and Major Businesses
Table 96. Insilico Medicine Product Features and Attributes
Table 97. Insilico Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Insilico Medicine Recent Developments
Table 99. Schrödinger Corporation Information
Table 100. Schrödinger Description and Major Businesses
Table 101. Schrödinger Product Features and Attributes
Table 102. Schrödinger Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Schrödinger Recent Developments
Table 104. BenevolentAI Corporation Information
Table 105. BenevolentAI Description and Major Businesses
Table 106. BenevolentAI Product Features and Attributes
Table 107. BenevolentAI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. BenevolentAI Recent Developments
Table 109. Evotec Corporation Information
Table 110. Evotec Description and Major Businesses
Table 111. Evotec Product Features and Attributes
Table 112. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Evotec Recent Developments
Table 114. PeptiFinder Corporation Information
Table 115. PeptiFinder Description and Major Businesses
Table 116. PeptiFinder Product Features and Attributes
Table 117. PeptiFinder Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. PeptiFinder Recent Developments
Table 119. Xtalpi Corporation Information
Table 120. Xtalpi Description and Major Businesses
Table 121. Xtalpi Product Features and Attributes
Table 122. Xtalpi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Xtalpi Recent Developments
Table 124. Sun Novo Corporation Information
Table 125. Sun Novo Description and Major Businesses
Table 126. Sun Novo Product Features and Attributes
Table 127. Sun Novo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Sun Novo Recent Developments
Table 129. Zonsen Peplib Biotech Corporation Information
Table 130. Zonsen Peplib Biotech Description and Major Businesses
Table 131. Zonsen Peplib Biotech Product Features and Attributes
Table 132. Zonsen Peplib Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Zonsen Peplib Biotech Recent Developments
Table 134. Tide Tron Biotech Corporation Information
Table 135. Tide Tron Biotech Description and Major Businesses
Table 136. Tide Tron Biotech Product Features and Attributes
Table 137. Tide Tron Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Tide Tron Biotech Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. AI-driven Peptide Drug Discovery Platform Product Picture
Figure 2. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Design and Generation Platform Product Picture
Figure 4. Screening and Optimization Platform Product Picture
Figure 5. Data-driven Platform Product Picture
Figure 6. Others Product Picture
Figure 7. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Scientific Research
Figure 9. Pharmaceuticals
Figure 10. AI-driven Peptide Drug Discovery Platform Report Years Considered
Figure 11. Global AI-driven Peptide Drug Discovery Platform Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 13. Global AI-driven Peptide Drug Discovery Platform Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Region (2020-2031)
Figure 15. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Design and Generation Platform Revenue Market Share by Player in 2024
Figure 18. Screening and Optimization Platform Revenue Market Share by Player in 2024
Figure 19. Data-driven Platform Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2020-2031)
Figure 22. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2020-2031)
Figure 23. North America AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024
Figure 25. North America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)
Figure 27. US AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 28. Canada AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 30. Europe AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024
Figure 32. Europe AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 35. France AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 37. Italy AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 38. Russia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 44. Japan AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 46. Australia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 47. India AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024
Figure 55. Central and South America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024
Figure 61. South America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)
Figure 64. Israel AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)
Figure 67. AI-driven Peptide Drug Discovery Platform Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of AI-driven Peptide Drug Discovery Platform in 2025?
The global market size of AI-driven Peptide Drug Discovery Platform in 2025 was 779 Million USD.
Which region is expected to have the highest market share?
What was the global market size of AI-driven Peptide Drug Discovery Platform in 2031?
What is the annual compound growth rate of the global AI-driven Peptide Drug Discovery Platform market size from 2025 to 2031?
Which companies rank high in the global AI-driven Peptide Drug Discovery Platform market?
Related Reports
Global AI-driven Peptide Drug Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ 779 million in 2025 to US$ 1435 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 150
USD 4900.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-driven Peptide Drug Discovery Platform market size was US$ 779 million in 2025 and is forecast to reach a readjusted size of US$ 1435 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 108
USD 4250.00
(Single User License)
AI-driven Peptide Drug Discovery Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-driven Peptide Drug Discovery Platform was estimated to be worth US$ 779 million in 2025 and is projected to reach US$ 1435 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 140
USD 3950.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Market Research Report 2026
The global AI-driven Peptide Drug Discovery Platform market was valued at US$ 779 million in 2025 and is anticipated to reach US$ 1435 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 130
USD 2900.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-driven Peptide Drug Discovery Platform market size was US$ 715 million in 2024 and is forecast to a readjusted size of US$ 1324 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 102
USD 4250.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Market Insights, Forecast to 2031
The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ 779 million in 2025 to US$ 1324 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period.
Published Date: 2025-05-15
Pages: 147
USD 4900.00
(Single User License)
AI-driven Peptide Drug Discovery Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-driven Peptide Drug Discovery Platform was estimated to be worth US$ 715 million in 2024 and is forecast to a readjusted size of US$ 1324 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-05-15
Pages: 126
USD 3950.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Market Research Report 2025
The global market for AI-driven Peptide Drug Discovery Platform was valued at US$ 715 million in the year 2024 and is projected to reach a revised size of US$ 1324 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-05-15
Pages: 98
USD 2900.00
(Single User License)
Global and United States AI-driven Peptide Drug Discovery Platform Market Report & Forecast 2024-2030
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
Published Date: 2024-09-25
Pages: 108
USD 4350.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Market Research Report 2024
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
Published Date: 2024-09-25
Pages: 84
USD 2900.00
(Single User License)
Global AI-driven Peptide Drug Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ 779 million in 2025 to US$ 1435 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 150
USD 4900.00 (Single User License)Global AI-driven Peptide Drug Discovery Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-driven Peptide Drug Discovery Platform market size was US$ 779 million in 2025 and is forecast to reach a readjusted size of US$ 1435 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 108
USD 4250.00 (Single User License)AI-driven Peptide Drug Discovery Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-driven Peptide Drug Discovery Platform was estimated to be worth US$ 779 million in 2025 and is projected to reach US$ 1435 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 140
USD 3950.00 (Single User License)Global AI-driven Peptide Drug Discovery Platform Market Research Report 2026
The global AI-driven Peptide Drug Discovery Platform market was valued at US$ 779 million in 2025 and is anticipated to reach US$ 1435 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-09
Pages: 130
USD 2900.00 (Single User License)Global AI-driven Peptide Drug Discovery Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-driven Peptide Drug Discovery Platform market size was US$ 715 million in 2024 and is forecast to a readjusted size of US$ 1324 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 102
USD 4250.00 (Single User License)Global AI-driven Peptide Drug Discovery Platform Market Insights, Forecast to 2031
The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ 779 million in 2025 to US$ 1324 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period.
Published: 2025-05-15
Pages: 147
USD 4900.00 (Single User License)AI-driven Peptide Drug Discovery Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-driven Peptide Drug Discovery Platform was estimated to be worth US$ 715 million in 2024 and is forecast to a readjusted size of US$ 1324 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-05-15
Pages: 126
USD 3950.00 (Single User License)Global AI-driven Peptide Drug Discovery Platform Market Research Report 2025
The global market for AI-driven Peptide Drug Discovery Platform was valued at US$ 715 million in the year 2024 and is projected to reach a revised size of US$ 1324 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-05-15
Pages: 98
USD 2900.00 (Single User License)Global and United States AI-driven Peptide Drug Discovery Platform Market Report & Forecast 2024-2030
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
Published: 2024-09-25
Pages: 108
USD 4350.00 (Single User License)Global AI-driven Peptide Drug Discovery Platform Market Research Report 2024
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
Published: 2024-09-25
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now